Algisyl-LVR

DEVICE3 trials

Sponsors

LoneStar Heart, Inc.

Conditions

CardiomyopathyDilated CardiomyopathyHeart Failure

Phase 2

Safety and Feasibility of Algisyl-LVR™ as a Method of Left Ventricular Restoration in Patients With DCM Undergoing Open-heart Surgery

CompletedNCT00847964

LoneStar Heart, Inc.Dilated Cardiomyopathy

Start: 2009-02-28End: 2012-11-30Updated: 2012-11-30

A Randomized, Controlled Study to Evaluate Algisyl-LVR™ as a Method of Left Ventricular Augmentation for Heart Failure

CompletedNCT01311791

LoneStar Heart, Inc.Dilated Cardiomyopathy, Heart Failure

Start: 2012-08-31End: 2016-05-31Updated: 2017-03-15

Unknown Phase

An Open Label Rollover Trial for Patients Randomized to the Control Group of Study LSH-10-001

LoneStar Heart, Inc.Cardiomyopathy, Dilated Cardiomyopathy, Heart Failure

Start: 2014-01-31End: 2016-04-30Target: 24Updated: 2014-08-27

Related Papers

A prospective comparison of alginate-hydrogel with standard medical therapy to determine impact on functional capacity and clinical outcomes in patients with advanced heart failure (AUGMENT-HF trial)

European Heart Journal2015-06-16169 citations